One study tested whether once-weekly semaglutide injections could help overweight or obese adults lose weight alongside lifestyle changes
Are there concurrent medications with interaction potential
Honigberg MC, Chang LS, McGuire DK, Plutzky J, Aroda VR, Vaduganathan M: Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review
Normal G-stimulation of TLR2 is beneficial to the enhancement of esophageal barrier function, but activation of the NF-B pathway through other pathways leads to esophageal barrier dysfunction when the microbiome is dysbiotic
In this context, therapies such as GLP-1RAs may represent a complementary strategy aimed at modulating both metabolic dysfunction and inflammation, thereby optimizing disease control and improving long-term outcomes in PsA
Bendotti, G., Montefusco, L., Lunati, M